Daniel J. Luckshire is the Executive Vice President and Chief Financial Officer at SIGA Technologies Inc., a position he has held since joining the company. With a robust background in finance and strategic management, Luckshire has been instrumental in steering SIGA Technologies towards financial stability and growth. Prior to his role at SIGA, he held various senior financial positions at other corporations, where he honed his skills in financial planning, analysis, and corporate strategy. At SIGA Technologies, Luckshire oversees all aspects of the company's financial operations, including financial reporting, budgeting, and investor relations. His strategic vision has been crucial in guiding the company through the complexities of the biopharmaceutical industry, particularly in the development and commercialization of medical countermeasures against biological threats. Under his leadership, SIGA has seen significant advancements in its financial health, which has enabled the company to invest in research and development and expand its product portfolio. Luckshire's achievements at SIGA Technologies are marked by his ability to navigate the company through challenging economic landscapes and regulatory environments. His expertise in financial management and strategic planning has not only strengthened SIGA's position in the market but also ensured its readiness to respond to public health emergencies. His contributions have been pivotal in establishing SIGA as a leader in the field of biodefense, and his ongoing role continues to drive the company's mission to protect public health.